Status:
RECRUITING
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
20+ years
Brief Summary
Introduction: Non-vitamin K antagonist oral anticoagulants (NOAC) is the first line therapy to prevent ischemic stroke or systemic thromboembolism among atrial fibrillation (AF) patients. Since 2016, ...
Eligibility Criteria
Inclusion
- Age more than 20 years.
- Under NOAC therapy.
Exclusion
- Failed to provide at least one blood sample for NOAC concentration measurement.
- Declined to provide informed consent
Key Trial Info
Start Date :
March 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT05333666
Start Date
March 21 2022
End Date
December 31 2028
Last Update
March 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Please Select, Taiwan, 100
2
National Taiwan University Hospital
Taipei, Taiwan, 100